Latest in Patient Experience

Sabinsa granted three patents in Canada, including uC3 CLEAR water-soluble curcumin

Sabinsa, a pioneer in nutraceutical and cosmeceutical industry, has strengthened its market position in Canada with the grant of three new patents

Find out more

Valensa awarded US patent for joint pain relief

The patent US10,624,919 covers a combination of hyaluronic acid and astaxanthin to alleviate joint deterioration, inflammation and pain

See more

Sigrid Therapeutics obtains US patent for silica-based biomaterial SiPore15 for the treatment and prevention of obesity

Mesoporous silica particles (MSP) are a type of ingestible synthetic amorphous silica particles that can be produced with a large surface area and a range of pore sizes

Biosearch Life applies for a new patent for the treatment of female infertility

The market for food supplements targeting fertility internationally is expected to grow at a rate of 7.8% and with a positive trend towards products that include natural ingredients

Using IP to secure opportunities in the budding medical cannabis sector

The opportunities for innovation in medical cannabis dovetails with the opportunity to obtain patent protection for the resulting inventions by pharmaceutical companies, writes Callum McGuinn, Senior Associate and European Patent Attorney, Mewburn Ellis

Noramco announces provisional patent application of proprietary cannabidiol (CBD)

Filing with the US Patent and Trademark Office covers pure cannabidiol compositions

Victory for Rimfrost against Aker

The US patent authorities have found that patents related to krill oil and its production held by Aker Biomarine are un-patentable

What today’s food companies can learn from startups

Practical Innovation provides the 21st century recipe for successfully bringing a product from concept and ideation to launch

Arjuna natural’s BCM-95 curcumin granted new patent

High-potency turmeric extract receives coveted treatment patent from EPO

Sabinsa successfully protects its Curcumin C3 Reduct technology

Sabinsa Corporation has successfully concluded its Patent Infringement lawsuit against Olive Lifesciences. The United States District Court in New Jersey entered an judgment awarding Sabinsa over $850,000 in damages, enhanced damages, attorney’s fees, costs and interest

Latest posts in Patient Experience

OptiBiotix strengthens patent protection around low-calorie sweeteners

OptiBiotix Health has filed three new patents for its natural, calorie free sweet fibre development programmes

Kemin patents polyphenol retention technology

Patented drying technology retains beneficial polyphenols from harvested spearmint

Valensa International secures two new US joint health patents for FlexPro MD

Zanthin natural astaxanthin and Flexuron Plus give Valensa 18 US patents protecting the core ingredients in its flagship joint healthcare portfolio

Bayir announces new patent for groundbreaking applications of curcumin

Bayir, a manufacturer of premium quality ingredients for the dietary supplement, functional food and beverage and nutraceutical industries, recently announced the approval of a process patent for synthesising curcumin nanoparticles

Sabinsa granted US patent for synbiotic composition of Lactospore shelf-stable probiotic and cranberry fibres

Sabinsa has been granted a US patent for the company’s shelf-stable probiotic LactoSpore in combination with cranberry seed fibres

UltraSOL curcumin line and CurcuWin granted patent for sports performance benefits

OmniActive Health Technologies has been granted a US patent (US 9724311) for the highly bioavailable, clinically studied UltraSOL line of curcumin ingredients, including CurcuWIN, for their sports nutrition and performance benefits

New patents granted to Sabinsa’s cosmetics division in US/EU

Sabinsa Cosmetics, a division of the Sami Labs–Sabinsa Group, has been granted two new patents on novel cosmetic compositions, both developed from extensive research on combinations of the company’s branded ingredients

Sabinsa successfully protects its Curcumin C3 Reduct technology

Curcumin C3 Reduct is a registered trademark and patented product of Sabinsa Corp., and is protected under US Patent 6,653,327 and International Patents and Patents Pending

Lycored wins EU patent for skincare compositions

International wellness company Lycored has been awarded an EU patent for its carotenoid compositions for skincare

Neptune and Enzymotec reach patent agreement, ending all litigation

Both parties recognise respective company's patent strength

Kemin and OmniActive place human health above litigation

On 5 December 2016, OmniActive Health Technologies and Kemin Industries resolved their legal differences, placing the importance of human health above litigation

Blue light and macular carotenoids

OmniActive takes action to protect customers and market

Sponsor content

Amin Talati Wasserman included in prestigious Chamber rankings of top law firms

The law firm is ranked in the category of food and beverages: regulatory and litigation in the USA, nationwide

Sabinsa's legal victory over Olive Lifesciences profiled in prominent law journal

The article recognises Sabinsa defending its intellectual property and cautions future patent infringement defendants against going rogue and neglecting to follow court...

Kemin requests ITC investigation of OmniActives

Kemin said its FloraGLO product is the only lutein brand supported by a patent that shows how ocular antioxidants, such as lutein and zeaxanthin, filter blue light to help...

EnWave announces new patent approval

The patent protects the improved modular design of EnWave's nutraREV machinery